{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T22:14:49Z","timestamp":1791756889322,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T00:00:00Z","timestamp":1567209600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T00:00:00Z","timestamp":1567209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008309","name":"Johns Hopkins Bloomberg School of Public Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008309","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12954-019-0320-8","type":"journal-article","created":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T09:35:37Z","timestamp":1567244137000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Acceptability of safe drug consumption spaces among people who inject drugs in rural West Virginia"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0735-9679","authenticated-orcid":false,"given":"Allison","family":"O\u2019Rourke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca Hamilton","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Nyeong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Kilkenny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan G.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean T.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,31]]},"reference":[{"key":"320_CR1","doi-asserted-by":"crossref","unstructured":"Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths \u2013 United States, 2013-2017. Morb Mortal Wkly Rep. ePub: 2018.","DOI":"10.15585\/mmwr.mm675152e1"},{"key":"#cr-split#-320_CR2.1","unstructured":"Nash, B. Herald Dispatch. Cabell led state in overdose deaths in 2017"},{"key":"#cr-split#-320_CR2.2","unstructured":"non-fatal pace slowing. (2018).  https:\/\/www.herald-dispatch.com\/news\/cabell-led-state-in-overdose-deaths-in-non-fatal-pace\/article_e6085520-c817-5bce-a793-c1bcdabe844b.html    . Accessed on 7 Mar 2019."},{"issue":"9737","key":"320_CR3","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S0140-6736(10)60743-X","volume":"376","author":"Steffanie A Strathdee","year":"2010","unstructured":"Strathdee SA, Hallett TB, Bobrova N, Rhodes T, Booth R, Abdool R, et al. HIV and risk environment for injecting drug users: the past, present, and future. Lancet. 2010. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(10)60743-X\n                    \n                  .","journal-title":"The Lancet"},{"issue":"1","key":"320_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/jurban\/jth083","volume":"81","author":"D Vlahov","year":"2004","unstructured":"Vlahov D, Fuller C, Ompad D, Galea S, Des JD. Updating the infection risk reduction hierarchy: preventing transition into injection. J Urban Health. 2004;81(1):14\u20139.","journal-title":"J Urban Health."},{"issue":"1","key":"320_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2105\/AJPH.91.1.46","volume":"91","author":"J Lorvick","year":"2001","unstructured":"Lorvick J, Kral AH, Seal K, Gee L, Edlin BR. Prevalence and duration of hepatitis C among injection drug users in San Francisco. Calif. Am J Public Health. 2001;91(1):46\u20137.","journal-title":"Calif. Am J Public Health."},{"key":"320_CR6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/1471-2458-8-405","volume":"8","author":"E Lloyd-Smith","year":"2008","unstructured":"Lloyd-Smith E, Wood E, Zhang R, Tyndall MW, Montaner JS, Kerr T. Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study. BMC Public Health. 2008;8:405.","journal-title":"BMC Public Health."},{"issue":"10","key":"320_CR7","doi-asserted-by":"publisher","first-page":"e569","DOI":"10.1016\/S2352-3018(18)30176-0","volume":"5","author":"Gregg S Gonsalves","year":"2018","unstructured":"Gonsalves GS, Crawford FW. Dynamics of the HIV outbreak and response in Scott County, IN, USA, 2011\u201315: a modelling study. The Lancet HIV. 2018. \n                    https:\/\/doi.org\/10.1016\/S2352-3018(18)30176-0\n                    \n                  .","journal-title":"The Lancet HIV"},{"issue":"3","key":"320_CR8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/QAI.0000000000001098","volume":"73","author":"Michelle M. Van Handel","year":"2016","unstructured":"Van Handel MM, Rose CE, Hallisey EJ, et al. County-level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States. J Acquir Immune Defic Syndr. 2016. \n                    https:\/\/doi.org\/10.1097\/QAI.0000000000001098\n                    \n                  .","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"issue":"8","key":"320_CR9","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1093\/aje\/145.8.730","volume":"145","author":"MC Doherty","year":"1997","unstructured":"Doherty MC, Garfein RS, Vlahov D, Junge B, Rathouz PJ, Galai N, et al. Discarded needles do not increase soon after the opening of a needle exchange program. Am J Epidemiol. 1997;145(8):730\u20137.","journal-title":"Am J Epidemiol"},{"issue":"6","key":"320_CR10","doi-asserted-by":"publisher","first-page":"936","DOI":"10.2105\/AJPH.90.6.936","volume":"90","author":"MC Doherty","year":"2000","unstructured":"Doherty MC, Junge B, Rathouz P, Garfein RS, Riley E, Vlahov D. The effect of a needle exchange program on numbers of discarded needles: a 2-year follow-up. Am J Public Health. 2000;90(6):936\u20139.","journal-title":"Am J Public Health"},{"issue":"5","key":"320_CR11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1093\/phr\/114.5.439","volume":"114","author":"RS Broadhead","year":"1999","unstructured":"Broadhead RS, van Hulst Y, Heckathorn DD. The impact of a needle exchange\u2019s closure. Public Health Rep. 1999;114(5):439\u201347.","journal-title":"Public Health Rep"},{"issue":"5","key":"320_CR12","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/00126334-199205000-00021","volume":"5","author":"KJ Oliver","year":"1992","unstructured":"Oliver KJ, Friedman SR, Maynard H, Magnuson L, Des Jarlais DC. Impact of a needle exchange program on potentially infectious syringes in public places. J Acquir Immune Defic Syndr. 1992;5(5):534\u20135.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"320_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1353-8292(01)00024-7","volume":"7","author":"K Dovey","year":"2001","unstructured":"Dovey K, Fitzgerald J, Choi Y. Safety becomes danger: dilemmas of drug-use in public space. Health Place. 2001;7(4):319\u201331.","journal-title":"Health Place"},{"key":"320_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.drugpo.2018.11.007","volume":"64","author":"Alison Sutter","year":"2019","unstructured":"Sutter A, Curtis M, Frost T. Public drug use in eight U.S. cities: Health risks and other factors associated with place of drug use. Int J Drug Policy. 2018. \n                    https:\/\/doi.org\/10.1016\/j.drugpo.2018.11.007\n                    \n                  .","journal-title":"International Journal of Drug Policy"},{"key":"320_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.drugpo.2018.10.008","volume":"63","author":"Colleen L. Barry","year":"2019","unstructured":"Barry CL, Sherman SG, Stone E, et al. Arguments supporting and opposing legalization of safe consumption sites in the U.S. Int J Drug Policy. 2019. \n                    https:\/\/doi.org\/10.1016\/j.drugpo.2018.10.008\n                    \n                  .","journal-title":"International Journal of Drug Policy"},{"issue":"11","key":"320_CR16","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1503\/cmaj.060863","volume":"175","author":"E. Wood","year":"2006","unstructured":"Wood E, Tyndall MW, Montaner JS, Kerr T. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. CMAJ. 2006. \n                    https:\/\/doi.org\/10.1503\/cmaj.060863\n                    \n                  .","journal-title":"Canadian Medical Association Journal"},{"key":"320_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/09581590400027528","volume":"14","author":"I van Beek","year":"2004","unstructured":"van Beek I, Dakin A, Kimber J, Gilmour S. The Sydney medically supervised injecting centre: reducing harm associated with heroin overdose. Critical public health. 2004;14:391\u2013406.","journal-title":"Critical public health."},{"issue":"10","key":"320_CR18","doi-asserted-by":"publisher","first-page":"e3351","DOI":"10.1371\/journal.pone.0003351","volume":"3","author":"M-J. S. Milloy","year":"2008","unstructured":"Milloy MJ, Kerr T, Tyndall M, Montaner J, Wood E. Estimated drug overdose deaths averted by North America\u2019s first medically-supervised safer injection facility. PLoS ONE. 2008. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0003351\n                    \n                  .","journal-title":"PLoS ONE"},{"key":"320_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.drugalcdep.2014.10.012","volume":"145","author":"Chlo\u00e9 Potier","year":"2014","unstructured":"Potier C, Lapr\u00e9vote V, Dubois-arber F, Cottencin O, Rolland B. Supervised injection services: what has been demonstrated? A systematic literature review. Drug Alcohol Depend. 2014. \n                    https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.10.012\n                    \n                  .","journal-title":"Drug and Alcohol Dependence"},{"issue":"7","key":"320_CR20","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1503\/cmaj.1040774","volume":"171","author":"E. Wood","year":"2004","unstructured":"Wood E, Kerr T, Small W, et al. Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. CMAJ. 2004. \n                    https:\/\/doi.org\/10.1503\/cmaj.1040774\n                    \n                  .","journal-title":"Canadian Medical Association Journal"},{"issue":"2-3","key":"320_CR21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.drugalcdep.2010.07.023","volume":"113","author":"Kora DeBeck","year":"2011","unstructured":"Debeck K, Kerr T, Bird L, et al. Injection drug use cessation and use of North America\u2019s first medically supervised safer injecting facility. Drug Alcohol Depend. 2011. \n                    https:\/\/doi.org\/10.1016\/j.drugalcdep.2010.07.023\n                    \n                  .","journal-title":"Drug and Alcohol Dependence"},{"key":"320_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2017.08.003","volume":"82","author":"Andrew Gaddis","year":"2017","unstructured":"Gaddis A, Kennedy MC, Nosova E, et al. Use of on-site detoxification services co-located with a supervised injection facility. J Subst Abuse Treat. 2017. \n                    https:\/\/doi.org\/10.1016\/j.jsat.2017.08.003\n                    \n                  .","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"320_CR23","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.drugalcdep.2005.11.011","volume":"83","author":"Mark W. Tyndall","year":"2006","unstructured":"Tyndall MW, Kerr T, Zhang R, King E, Montaner JG, Wood E. Attendance, drug use patterns, and referrals made from North America\u2019s first supervised injection facility. Drug Alcohol Depend. 2006. \n                    https:\/\/doi.org\/10.1016\/j.drugalcdep.2005.11.011\n                    \n                  .","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"320_CR24","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/j.1360-0443.2007.01818.x","volume":"102","author":"Evan Wood","year":"2007","unstructured":"Wood E, Tyndall MW, Zhang R, Montaner JS, Kerr T. Rate of detoxification service use and its impact among a cohort of supervised injecting facility users. Addiction. 2007. \n                    https:\/\/doi.org\/10.1111\/j.1360-0443.2007.01818.x\n                    \n                  .","journal-title":"Addiction"},{"issue":"9775","key":"320_CR25","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/S0140-6736(10)62353-7","volume":"377","author":"Brandon DL Marshall","year":"2011","unstructured":"Marshall BD, Milloy MJ, Wood E, Montaner JS, Kerr T. Reduction in overdose mortality after the opening of North America\u2019s first medically supervised safer injecting facility: a retrospective population-based study. Lancet. 2011. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(10)62353-7\n                    \n                  .","journal-title":"The Lancet"},{"key":"320_CR26","doi-asserted-by":"publisher","unstructured":"Irwin A, Jozaghi E, Weir BW, Allen ST, Lindsay A, Sherman SG. Mitigating the heroin crisis in Baltimore, MD, USA: a cost-benefit analysis of a hypothetical supervised injection facility. Harm Reduct J. 2017. \n                    https:\/\/doi.org\/10.1186\/s12954-017-0153-2\n                    \n                  .","DOI":"10.1186\/s12954-017-0153-2"},{"key":"320_CR27","doi-asserted-by":"publisher","unstructured":"Jozaghi E, Reid AA, Andresen MA. A cost-benefit\/cost-effectiveness analysis of proposed supervised injection facilities in Montreal, Canada. Subst Abuse Treat Prev Policy. 2013. \n                    https:\/\/doi.org\/10.1186\/1747-597X-8-25\n                    \n                  .","DOI":"10.1186\/1747-597X-8-25"},{"key":"320_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1747-597X-1-13","volume":"1","author":"E Wood","year":"2006","unstructured":"Wood E, Tyndall MW, Lai C, Montaner JS, Kerr T. Impact of a medically supervised safer injecting facility on drug dealing and other drug-related crime. Subst Abuse Treat Prev Policy. 2006;1:13.","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"2","key":"320_CR29","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/09595230500167460","volume":"24","author":"K Freeman","year":"2005","unstructured":"Freeman K, Jones CG, Weatherburn DJ, Rutter S, Spooner CJ, Donnelly N. The impact of the Sydney Medically Supervised Injecting Centre (MSIC) on crime. Drug Alcohol Rev. 2005;24(2):173\u201384.","journal-title":"Drug Alcohol Rev."},{"issue":"4","key":"320_CR30","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/j.1360-0443.2009.02837.x","volume":"105","author":"Allison M. Salmon","year":"2010","unstructured":"Salmon AM, Van Beek I, Amin J, Kaldor J, Maher L. The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia. Addiction. 2010. \n                    https:\/\/doi.org\/10.1111\/j.1360-0443.2009.02837.x\n                    \n                  .","journal-title":"Addiction"},{"key":"320_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.drugpo.2017.11.005","volume":"52","author":"Robert E. Harris","year":"2018","unstructured":"Harris RE, Richardson J, Frasso R, Anderson ED. Perceptions about supervised injection facilities among people who inject drugs in Philadelphia. Int J Drug Policy. 2018. \n                    https:\/\/doi.org\/10.1016\/j.drugpo.2017.11.005\n                    \n                  .","journal-title":"International Journal of Drug Policy"},{"issue":"1-2","key":"320_CR32","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.drugalcdep.2010.02.009","volume":"110","author":"Alex H. Kral","year":"2010","unstructured":"Kral AH, Wenger L, Carpenter L, Wood E, Kerr T, Bourgois P. Acceptability of a safer injection facility among injection drug users in San Francisco. Drug Alcohol Depend. 2010. \n                    https:\/\/doi.org\/10.1016\/j.drugalcdep.2010.02.009\n                    \n                  .","journal-title":"Drug and Alcohol Dependence"},{"key":"320_CR33","doi-asserted-by":"publisher","unstructured":"Bouvier BA, Elston B, Hadland SE, Green TC, Marshall BD. Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study. Harm Reduct J. 2017. \n                    https:\/\/doi.org\/10.1186\/s12954-017-0139-0\n                    \n                  .","DOI":"10.1186\/s12954-017-0139-0"},{"issue":"3","key":"320_CR34","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s11524-019-00365-1","volume":"96","author":"Ju Nyeong Park","year":"2019","unstructured":"Park JN, Rouhani S, Morales K, Green TC, McKenzie M, Marshall BDL, Sherman SG. Willingness to use safer consumption spaces among opioid users at high risk of fentanyl overdose in Baltimore, Providence, and Boston. J Urban Health. 2019. \n                    https:\/\/doi.org\/10.1007\/s11524-019-00365-1\n                    \n                  .","journal-title":"Journal of Urban Health"},{"issue":"3","key":"320_CR35","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2105\/AJPH.2018.304873","volume":"109","author":"Sean T. Allen","year":"2019","unstructured":"Allen ST, O\u2019Rourke A, White RH, Schneider KE, Kilkenny M, Sherman SG. Estimating the number of people who inject drugs in a rural county in Appalachia. Am J Public Health. 2019. \n                    https:\/\/doi.org\/10.2105\/AJPH.2018.304873\n                    \n                  .","journal-title":"American Journal of Public Health"},{"key":"320_CR36","unstructured":"Allen ST, O\u2019Rourke A, White RH, Schneider KE, Hazelett T, Kilkenny M, Sherman SG. 2019. Applying population estimation methods in rural America. Retrieved from \n                    https:\/\/americanhealth.jhu.edu\/themes\/bahi_stable\/assets\/pdfs\/Opioid_Services_Toolkit_012419.pdf\n                    \n                  . Accessed on 27 June 2019."},{"key":"320_CR37","unstructured":"Allen ST, O\u2019Rourke A., White RH, Schneider KE, Hazelett T, Kilkenny M, Sherman SG. 2019. Rural communities in crisis. Retrieved from. \n                    https:\/\/americanhealth.jhu.edu\/RuralOpioidsCount\n                    \n                  . Accessed on 27 June 2019."},{"issue":"1","key":"320_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12954-019-0305-7","volume":"16","author":"ST Allen","year":"2019","unstructured":"Allen ST, Grieb SM, O\u2019Rourke A, Yoder R, Planchet E, White RH, Sherman SG. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs. Harm Reduct J. 2019;16(1):33. \n                    https:\/\/doi.org\/10.1186\/s12954-019-0305-7\n                    \n                  .","journal-title":"Harm Reduct J."},{"issue":"1","key":"320_CR39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3109\/00952990.2011.600389","volume":"38","author":"Kora DeBeck","year":"2011","unstructured":"Debeck K, Kerr T, Lai C, Buxton J, Montaner J, Wood E. The validity of reporting willingness to use a supervised injecting facility on subsequent program use among people who use injection drugs. Am J Drug Alcohol Abuse. 2012. \n                    https:\/\/doi.org\/10.3109\/00952990.2011.600389\n                    \n                  .","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"320_CR40","volume-title":"Insider. A fire chief in West Virginia helped change her city\u2019s approach to the opioid epidemic. Now overdoses in her county are down 40%","author":"C Praderio","year":"2019","unstructured":"Praderio, C. Insider. A fire chief in West Virginia helped change her city\u2019s approach to the opioid epidemic. Now overdoses in her county are down 40% (2019). \n                    https:\/\/www.thisisinsider.com\/west-virginia-fire-chief-jan-rader-opioid-epidemic-ted-talk-2018-12\n                    \n                  . Accessed on 6 Feb 2019."}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-019-0320-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12954-019-0320-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-019-0320-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T23:08:34Z","timestamp":1598742514000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-019-0320-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,31]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["320"],"URL":"https:\/\/doi.org\/10.1186\/s12954-019-0320-8","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,31]]},"assertion":[{"value":"15 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants were verbally consented. This study was approved by the Johns Hopkins Institutional Review Board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}